These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 23928345)

  • 21. Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P).
    Tanaka KA; Taketomi T; Szlam F; Calatzis A; Levy JH
    Anesth Analg; 2008 Mar; 106(3):732-8, table of contents. PubMed ID: 18292410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rational and timely haemostatic interventions following cardiac surgery - coagulation factor concentrates or blood bank products.
    Tang M; Fenger-Eriksen C; Wierup P; Greisen J; Ingerslev J; Hjortdal V; Sørensen B
    Thromb Res; 2017 Jun; 154():73-79. PubMed ID: 28437748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series.
    Schultz NH; Lundblad R; Holme PA
    J Med Case Rep; 2018 May; 12(1):138. PubMed ID: 29764497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of rivaroxaban anticoagulation by haemostatic agents in rats and primates.
    Perzborn E; Gruber A; Tinel H; Marzec UM; Buetehorn U; Buchmueller A; Heitmeier S; Laux V
    Thromb Haemost; 2013 Jul; 110(1):162-72. PubMed ID: 23636219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dabigatran and its reversal with recombinant factor VIIa and prothrombin complex concentrate: a Sonoclot in vitro study.
    Sølbeck S; Nilsson CU; Engström M; Ostrowski SR; Johansson PI
    Scand J Clin Lab Invest; 2014 Oct; 74(7):591-8. PubMed ID: 24909158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective study of rFVIIa, 4-factor PCC, and a rFVIIa and 3-factor PCC combination in improving bleeding outcomes in the warfarin and non-warfarin patient.
    DeLoughery E; Avery B; DeLoughery TG
    Am J Hematol; 2016 Jul; 91(7):705-8. PubMed ID: 27074566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of apixaban induced alterations in hemostasis by different coagulation factor concentrates: significance of studies in vitro with circulating human blood.
    Escolar G; Fernandez-Gallego V; Arellano-Rodrigo E; Roquer J; Reverter JC; Sanz VV; Molina P; Lopez-Vilchez I; Diaz-Ricart M; Galan AM
    PLoS One; 2013; 8(11):e78696. PubMed ID: 24244342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant factor VIIa reduces bleeding after blunt liver injury in coagulopathic, hypofibrinogenaemic pigs.
    Grottke O; Braunschweig T; Zimmermann L; Kopp R; Lauritzen B; Coburn M; Tolba R; Rossaint R
    Br J Anaesth; 2010 Dec; 105(6):789-97. PubMed ID: 20926476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation.
    Tanaka KA; Szlam F; Dickneite G; Levy JH
    Thromb Res; 2008; 122(1):117-23. PubMed ID: 17977586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Low Dose Recombinant Factor VIIa and 4-Factor Prothrombin Complex Concentrate for Treatment of Bleeding Related to Cardiac Surgery.
    Caldwell L; Bhakta R; Naik N; Knowles BD; Parker J; Van Berkel Patel M
    J Pharm Pract; 2024 Oct; 37(5):1149-1156. PubMed ID: 38261533
    [No Abstract]   [Full Text] [Related]  

  • 31. A direct thrombin inhibitor studied by dynamic whole blood clot formation. Haemostatic response to ex-vivo addition of recombinant factor VIIa or activated prothrombin complex concentrate.
    Sørensen B; Ingerslev J
    Thromb Haemost; 2006 Oct; 96(4):446-53. PubMed ID: 17003921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global coagulation tests: their applicability for measuring direct factor Xa- and thrombin inhibition and reversal of anticoagulation by prothrombin complex concentrate.
    Dinkelaar J; Patiwael S; Harenberg J; Leyte A; Brinkman HJ
    Clin Chem Lab Med; 2014 Nov; 52(11):1615-23. PubMed ID: 24902009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective reversal of edoxaban-associated bleeding with four-factor prothrombin complex concentrate in a rabbit model of acute hemorrhage.
    Herzog E; Kaspereit F; Krege W; Doerr B; Mueller-Cohrs J; Pragst I; Morishima Y; Dickneite G
    Anesthesiology; 2015 Feb; 122(2):387-98. PubMed ID: 25419685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Prothrombin Complex Concentrate with Activated Factor VII Use for Bleeding Following Cardiopulmonary Bypass in Children.
    Benson JW; Hraska V; Scott JP; Stuth EAE; Yan K; Zhang J; Niebler RA
    World J Pediatr Congenit Heart Surg; 2023 May; 14(3):282-288. PubMed ID: 36919404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate.
    Lindahl TL; Wallstedt M; Gustafsson KM; Persson E; Hillarp A
    Thromb Res; 2015 Mar; 135(3):544-7. PubMed ID: 25596769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of dabigatran effects in models of thrombin generation and hemostasis by factor VIIa and prothrombin complex concentrate.
    Hoffman M; Volovyk Z; Monroe DM
    Anesthesiology; 2015 Feb; 122(2):353-62. PubMed ID: 25502064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo increase in thrombin generation by four-factor prothrombin complex concentrate in apixaban-treated healthy volunteers.
    Cheung YW; Barco S; Hutten BA; Meijers JC; Middeldorp S; Coppens M
    J Thromb Haemost; 2015 Oct; 13(10):1799-805. PubMed ID: 26270625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of recombinant activated factor VII vs. plasma-derived activated prothrombin complex concentrate in the treatment of mild-to-moderate bleeding episodes in patients with severe haemophilia A and inhibitors in Spain.
    Jimenez-Yuste V; Núñez R; Romero JA; Montoro B; Espinós B
    Haemophilia; 2013 Nov; 19(6):841-6. PubMed ID: 23758100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abrupt oxygen decrease influences thrombosis and bleeding in stenosed and endothelium-injured rabbit carotid arteries.
    Dellamonica J; Mazoyer E; Rosa JP; Cymbalista F; Samama C
    Eur J Anaesthesiol; 2008 Dec; 25(12):1002-8. PubMed ID: 18471336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombotic safety of prothrombin complex concentrate (Beriplex P/N) for dabigatran reversal in a rabbit model.
    Herzog E; Kaspereit FJ; Krege W; Doerr B; van Ryn J; Dickneite G; Pragst I
    Thromb Res; 2014 Sep; 134(3):729-36. PubMed ID: 25084749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.